Metastatic renal cell carcinoma and Hypoacusis

Summary:

Hypoacusis is found among people with Metastatic renal cell carcinoma, especially for people who are male, 60+ old.

The study analyzes which people have Hypoacusis with Metastatic renal cell carcinoma. It is created by eHealthMe based on reports of 36 people who have Metastatic renal cell carcinoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Metastatic renal cell carcinoma?

Metastatic renal cell carcinoma (spreadable kidney cell tumour) is found to be associated with 258 drugs and 322 conditions by eHealthMe. Check the latest studies of Metastatic renal cell carcinoma.

What is Hypoacusis?

Hypoacusis (loss of hearing) is found to be associated with 1,336 drugs and 1,187 conditions by eHealthMe. Check the latest studies of Hypoacusis.



On Aug, 01, 2026

36 people who have Metastatic Renal Cell Carcinoma and Hypoacusis are studied.

Would you have Hypoacusis when you have Metastatic renal cell carcinoma?

Gender of people who have Metastatic Renal Cell Carcinoma and experienced Hypoacusis *:

  • female: 19.44 %
  • male: 80.56 %

Age of people who have Metastatic Renal Cell Carcinoma and experienced Hypoacusis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.03 %
  • 40-49: 0.0 %
  • 50-59: 3.03 %
  • 60+: 93.94 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 8 people, 22.22%
  2. High Blood Cholesterol: 6 people, 16.67%
  3. Thyroid Diseases: 5 people, 13.89%
  4. Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 5 people, 13.89%
  5. Pain: 4 people, 11.11%
  6. Constipation: 4 people, 11.11%
  7. Depression: 3 people, 8.33%
  8. Diarrhea: 3 people, 8.33%
  9. Hypersensitivity: 3 people, 8.33%
  10. Renal Cancer Metastatic (cancer of kidney spreads to other part): 3 people, 8.33%

Common drugs taken by these people *:

  1. Sutent: 22 people, 61.11%
  2. Inlyta: 5 people, 13.89%
  3. Votrient: 4 people, 11.11%
  4. Calcium: 4 people, 11.11%
  5. Lipitor: 4 people, 11.11%
  6. Prilosec: 4 people, 11.11%
  7. Cozaar: 3 people, 8.33%
  8. Vitamin D3: 3 people, 8.33%
  9. Protonix: 3 people, 8.33%
  10. Oxycodone: 3 people, 8.33%

Common symptoms for these people *:

  1. Diarrhea: 21 people, 58.33%
  2. Fatigue (feeling of tiredness): 20 people, 55.56%
  3. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 16 people, 44.44%
  4. Pain In Extremity: 14 people, 38.89%
  5. High Blood Pressure: 14 people, 38.89%
  6. Weakness: 12 people, 33.33%
  7. Nausea (feeling of having an urge to vomit): 12 people, 33.33%
  8. Indigestion: 11 people, 30.56%
  9. Cough: 11 people, 30.56%
  10. Rashes (redness): 10 people, 27.78%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hypoacusis?

- Check whether Hypoacusis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hypoacusis:

All the conditions that are associated with Hypoacusis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hypoacusis and Metastatic renal cell carcinoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: